Innovation Pharmaceuticals Inc (IPIX)

[olden_grumpini]

Brilacidin as vaccine.

The vaccine isn't entirely off the table, but in the PR IPIX issued on 5/19 they said the following:

Separately, the Company and laboratory researchers (from a different testing facility) agreed that Brilacidin as a vaccine would not be studied further at this time. While the vaccine pathway remains of interest, the Company is prioritizing Brilacidin’s clinical development as a potential novel COVID-19 treatment, and thus is taking steps to rapidly advance Brilacidin into human trials.

Innovation Pharmaceuticals’ Brilacidin Reduces Viral Titer of SARS-CoV-2 (COVID-19) by 75 Percent After Only 1 Hour of Preincubation in In Vitro Study at BSL-3 Facility